Atezolizumab Plus Chemo Misses Mark in TNBC ...Middle East

Medscape - News
The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with stages II-III triple-negative breast cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Atezolizumab Plus Chemo Misses Mark in TNBC )

Also on site :